Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NICE

First osteoporosis drug of its kind for more than a decade approved for NHS use

The drug is one of only two treatments that help to promote bone formation, and the first to reduce bone loss at the same time.

The Independent UK

Former Liverpool striker Mario Balotelli gets new face tattoo

Ex-Liverpool striker Mario Balotelli has posted on Instagram a photo showing off his new face tattoo

Liverpool Echo

Patrick Vieira found out the hard way why Cesc Fabregas "made him leave Arsenal"

A LOOK BACK: The legendary French midfielder was adored by the Arsenal faithful for his elegant, technical prowess mixed with tough-tackling and a fierce temper - but he was eventually ousted by a teenager

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Pregnant women to receive life-saving pre-eclampsia blood test on the NHS

Women are to receive a life-saving blood test under the NHS thanks to new guidelines. As a result, the test could save many lives and many hospitals have already started using the placental growth factor (PLGF) test.

Glasgow Live

Pregnant women to be offered test to detect pre-eclampsia

Early signs of the condition include high blood pressure and protein in the urine

Wales Online

NICE: CM will convene meeting to resolve issues, says Nirani

Bengaluru

The Hindu

Relieving CSRs from repetitive manual work with attended automation

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Take over NICE project, urge JD(S) MLCs

‘Twenty-three years after the project was started, it is still not completed’

The Hindu

3 Tech Stocks to Scoop Up After Sharp Declines: Seagate Technology, NICE, and Ericsson

Skyrocketing inflation, rising interest rates, and a geopolitical crisis caused by Russia’s invasion of Ukraine, have triggered massive selloffs in the technology sector. However, these conditions represent a great opportunity to buy stocks on their price dips. So, we think it could be wise to invest in financially solid tech…

StockNews.com

Health watchdog NICE reveals 'landmark' better care for those exposed to alcohol in womb

Fetal Alcohol Spectrum Disorder (FASD) is a neurodevelopmental condition with potentially 'devastating' consequences - but families affected have felt largely 'unsupported'

Daily Mirror

NICE land to cost BMRCL ₹100 crore

However, KIADB will have a final say on how much NICE will get after studying property documents

The Hindu

3 Tech Stocks Down More Than 25% to Scoop Up Now: NICE, Vivint, and Semtech

The technology sector has been accelerating since the onset of the COVID-19 pandemic, thanks to rapid digitalization and with it the adoption of advanced technologies and cloud-based solutions by almost every sector. While bearish market trends currently are putting pressure on tech stocks, we think it could be wise to…

StockNews.com

Hatem Ben Arfa at 35: Dazzling highs and irritating lows of remarkable 18-year career

Hatem Ben Arfa is back playing Champions League football in the twilight of a career which promised much more than it ultimately delivered, having been arguably the most talented French footballer of his generation

Daily Mirror

Five9 vs. NICE Ltd.: Which Call Center Software Stock is a Better Buy?

As the call center software market is making leaps with continued digital transformation and hybrid lifestyle, prominent companies in this space, NICE (NICE) and Five9 (FIVN), should witness increasing demand for their solutions. But which of these stocks is a better buy now? Read more to find out.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Will Chart Analysts Notice Bad Omen on NICE's Chart

If history is any guide, there may be trouble ahead for shares of NICE (NASDAQ:NICE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Manchester Evening News

Manchester research contributes to ground-breaking peanut allergy treatment for children

“She can sense the level of reaction, and so we are able to deal with it, this has opened up her world."

Benzinga

NICE: Q4 Earnings Insights

NICE (NASDAQ:NICE) reported its Q4 earnings results on Thursday, February 17, 2022 at 05:30 AM. Here's what investors need to know about the announcement.

Benzinga

NICE Tops Q4 Backed By Cloud Momentum

NICE Ltd (NASDAQ:NICE) reported fourth-quarter FY21 non-GAAP revenue growth of 17.6% year on year to $515.5 million, beating the consensus of $496.1 million. Non-GAAP revenues from Cloud grew 28.1% Y/Y to $285 million. Non-GAAP gross margin expanded 80 bps to 73%, while the non-GAAP operating margin contracted 190 bps to 28.2%. Non-GAAP EPS…

Get all your
news in one place.

100’s of premium titles.
One news app.

Football London

Tanguy Ndombele's verdict on his start to life back at Lyon as Tottenham loanee impresses coach

Tanguy Ndombele recorded an assist at the weekend for Lyon in their win over Nice as the Tottenham Hotspur midfielder continues to enjoy his football on his return to France

The Independent UK

The NHS is now recommending revolutionary drug for obesity treatment

The drug suppresses appetite by mimicking a hormone that is released after eating

The Independent UK

NICE approves revolutionary drug for obesity treatment

The drug suppresses appetite by mimicking a hormone that is released after eating

The Independent UK

Thousands of obese people to get fat-busting drug on the NHS

In some cases, those with a BMI of 30 may be able to access semaglutide, which is given via a pen injector.

1 … 40 41 42 43

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.